OTC: SOLTF - Sosei Group Corporation

六个月盈利: -34.48%
股息率: 0.00%
部门: Healthcare

促销时间表 Sosei Group Corporation

先进的时间表 简单图表
Financial Markets by TradingView

关于公司 Sosei Group Corporation

Sosei Group Corporation develops biopharmaceutical products worldwide. Its marketed products include Ultibro/Breezhaler and Seebri/Breezhaler for the treatment of chronic obstructive pulmonary disease; Enerzair to treat asthma; and ORAVI, an oropharyngeal candidiasis.

更多详情
The company's product pipeline consists of GPR35 agonist, for inflammatory bowel disease/GI disorders, which is in preclinical stage; HTL0016878 for Schizophrenia and other neuropsychiatric disorders; PF-07081532 for Type 2 diabetes mellitus and obesity; PF-07054894 for inflammatory bowel disease; and PF-07258669 for anorexia. Sosei Group Corporation has a strategic collaboration with AbbVie, Biohaven, Genentech, GSK, Takeda, Pfizer, Neurocrine Biosciences, Novartis, Verily, AstraZeneca, and Takeda. The company was incorporated in 1990 and is headquartered in Tokyo, Japan.
添加到比较列表
添加到观察列表
添加到投资组合
添加价格通知

Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 0
Дивиденд ао 0.0673
Сайт https://soseiheptares.com
Цена ао 5.91
每日价格变化: 0% (5.91)
每周价格变化: 0% (5.91)
每月价格变化: -9.36% (6.52)
3个月内价格变化: -4.02% (6.1575)
六个月内的价格变化: -34.48% (9.02)
每年价格变化: -43.85% (10.526)
3年内价格变化: -54.11% (12.88)
5年内价格变化: -67.26% (18.05)
年初以来价格变化: -4.02% (6.1575)
所有参数

低估

姓名 意义 年级
P/S 9 1
P/BV 0.0122 10
P/E 325.54 1
EV/EBITDA -550.44 0
全部的: 4.25

效率

姓名 意义 年级
ROA, % -0.0325 0
ROE, % -0.0764 0
全部的: 0

股息

姓名 意义 年级
Div yield, % 0 0
DSI 0.5 5
全部的: 1.31

责任

姓名 意义 年级
Debt/EBITDA -1497.58 10
全部的: 10

成长冲动

姓名 意义 年级
盈利能力 Revenue, % -98.83 0
盈利能力 Ebitda, % -102.03 0
盈利能力 EPS, % -104.21 0
全部的: 0
更多详情

机构 体积 分享, %
Smallcap World Fund 1841200 2.06
Vanguard International Stock Index-Total Intl Stock Indx 997900 1.12
Vanguard Tax Managed Fund-Vanguard Developed Markets Index Fund 604000 0.68
iShares Core MSCI EAFE ETF 441300 0.49
iShares MSCI EAFE Small Cap ETF 284100 0.32
Vanguard Intl Equity Index Fds-FTSE All World ex U.S.Small Cap Index 278200 0.31
Schwab Strategic Tr-Schwab International Small Cap Equity ETF 149344 0.17
iShares Core MSCI Total International Stock ETF 129600 0.14
Vanguard International Stock Index-Pacific Stock Index 89400 0.1
iShares Core MSCI International Developed Markets ETF 62100 0.07



导师 职称 支付 出生年份
Mr. Christopher Cargill Representative Executive Officer, President, CEO & Director 1.25M 1984 (41 年)
Mr. Hironoshin Nomura Executive Officer, Executive VP & CFO N/A 1983 (42 年)
Mr. Kieran Johnson F.C.A. Executive Officer, Executive VP & Chief Accounting Officer N/A 1969 (56 年)
Mr. Toshihiro Maeda Executive VP & COO N/A 1979 (46 年)
Mr. Kazuhiko Yoshizumi Executive Officer, Executive VP & Chief Compliance Officer N/A 1954 (71 年)
Shinichiro Nishishita VP of Investor Relations & Head of Regulatory Disclosures N/A
Stacey Southall Associate Director & Head of Biophysics N/A
Ms. Candelle Chong Executive Officer, Executive VP, CEO Office & Chief of Staff N/A 1989 (36 年)
Dr. Satoshi Tanaka Exe. Off., Executive VP and President of Idorsia Pharmaceuticals Japan & Nxera Pharma Japan N/A 1957 (68 年)
Dr. Shinichi Tamura Founder & Chairman of the Board 1949 (76 年)

地址: Japan, Tokyo -, PMO Hanzomon - 在 Google 地图中打开, 打开 Yandex 地图
网站: https://soseiheptares.com